Providing value to new health technology: The early contribution of entrepreneurs, investors, and regulatory agencies

International Journal of Health Policy and Management

Volumn 6, Issue 9, 2017, Pages 509-518

  Lehoux, Pascale ^a   Miller, Fiona A ^b   Daudelin, Geneviève ^a   Denis, Jean Louis ^c,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ÉCOLE NATIONALE D'ADMINISTRATION PUBLIQUE   (Canada)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Early HTA; Health policy; Health technology development (HTA); Innovation policy; Technology based ventures

Indexed keywords

ECONOMICS; ENTREPRENEURSHIP; GOVERNMENT REGULATION; HEALTH CARE FINANCING; HEALTH SERVICE; HUMAN; INVENTION; INVESTMENT; LEGISLATION AND JURISPRUDENCE; MEDICAL TECHNOLOGY; ORGANIZATION AND MANAGEMENT; QUALITATIVE RESEARCH; QUEBEC;

BIOMEDICAL TECHNOLOGY; ENTREPRENEURSHIP; GOVERNMENT REGULATION; HEALTH SERVICES NEEDS AND DEMAND; HEALTHCARE FINANCING; HUMANS; INVENTIONS; INVESTMENTS; QUALITATIVE RESEARCH; QUEBEC;

EID: 85029221109     PISSN: None     EISSN: 23225939     Source Type: Journal    
DOI: 10.15171/ijhpm.2017.11     Document Type: Article

References (29)

1. Dixon-Woods M, Amalberti R, Goodman S, Bergman B, Glasziou P. Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new. BMJ Qual Saf. 2011;20:i47-i51 doi:10.1136/bmjqs.2010.046227 2
2. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O, Peacock R. Storylines of research in diffusion of innovation: a meta-narrative approach to systematic review. Soc Sci Med 2005;61(2):417-430. doi:10.1016/j.socscimed.2004.12.001
3. Gelijns AC, Russo MJ, Hong KN, Brown LD, Ascheim DD, Moskowitz AJ. Dynamics of device innovation: implications for assessing value. Int J Technol Assess Health Care. 2013;29(04):365-373. doi:10.1017/S0266462313000561
4. Leonardi PM, Barley S. What’s under construction here? Social action, materiality, and power in constructivist studies of technology and organizing. Acad Manag Ann 2010;4(1):1-51. doi:10.1080/19416521003654160
5. Lehoux P, Williams-Jones B, Miller F, Urbach D, Tailliez S. What leads to better health innovation? Arguments for an integrated policy-oriented research agenda. J Health Serv Res Policy. 2008;13(4):251-254. doi:10.1258/jhsrp.2008.007173
6. Henshall C, Schuller T. Health technology assessment, value-based decision making, and innovation. Int J Technol Assess Health Care. 2013;29(4):353-359. doi:10.1017/S0266462313000378
7. Markiewicz K, van Til JA, Ijzerman MJ. Medical devices early assessment methods: systematic literature review. Int J Technol Assess Health Care. 2014;30(2):137-146. doi:10.1017/S0266462314000026
8. Nielsen CP, Funch TM, Kristensen FB. Health technology assessment: research trends and future priorities in Europe. J Health Serv Res Policy. 2011;16(Suppl 2):6-15. doi:10.1258/jhsrp.2011.011050
9. Pietzsch JB, Paté-Cornell ME. Early technology assessment of new medical devices. Int J Technol Assess Health Care. 2008;24(1):36-44.
10. Lehoux P, Miller FA, Daudelin G, Urbach DR. How venture capital decide which new medical technologies come to exist? Sci Public Policy. 2015;43(3):375-385. doi:10.1093/scipol/scv051
11. Chesbrough H, Rosenbloom RS. The role of business model in capturing value from innovation: evidence from Xerox Corporation’s technology spin-off companies. Ind Corp Change 2002;11(3):529-555. doi:10.1093/icc/11.3.529
12. Sapolsky H. M. Managing the Medical Arms Race: Innovation and Public Policy in the Medical Device Industry. J Health Polit Policy Law. 1994;19(3):668-669.
13. Sampat B, Drummond M. Another special relationship? Interactions between health technology policies and health care systems in the United States and the United Kingdom. J Health Polit Policy Law. 2011;36(1):119-139. doi:10.1215/03616878-1191126
14. Garber S, Gates SM, Keeler EB. Redirecting Innovation in US Health Care: Options to Decrease Spending and Increase Value. Santa Monica, CA: RAND Corporation; 2014.
15. Robinson JC. Biomedical innovation in the era of health care spending constraints. Health Aff. 2015;34(2):203-209. doi:10.1377/hlthaff.2014.0975
16. Braunerhjelm P, Henrekson M. Entrepreneurship, institutions, and economic dynamism: lessons from a comparison of the United States and Sweden. Ind Corp Change. 2013;22(1):107-130. doi:10.1093/icc/dts048
17. Hirsch-Kreinsen H. Financial market and technological innovation. Ind Innov. 2011;18(4):351-368. doi:10.1080/136627 16.2011.573954
18. Nightingale P, Coad A. Muppets and gazelles: political and methodological biases in entrepreneurship research. Ind Corp Change. 2014;23(1):113-143. doi:10.1093/icc/dtt057
19. Horizon 2020 Work Programme 2016-2017. Innovation in SMEs. http://ec.europa.eu/research/participants/data/ref/h2020/wp/2016_2017/main/h2020-wp1617-sme_en.pdf.
20. Lehoux P, Daudelin G, Hivon M, Miller FA, Denis JL. How do values shape technology design? An exploration of what makes the pursuit of health and wealth legitimate in academic spinoffs. Sociol Health Illn. 2014;36(5):738-755. doi:10.1111/1467-9566.12097
21. Lehoux P, Daudelin G, Williams-Jones B, Denis JL, Longo C. How do business models and health technology design influence each other? Insights from a longitudinal case study of three academic spin-offs. Res Policy. 2014;43(6):1025-1038. doi:10.1016/j.respol.2014.02.001
22. Sutton RI. The virtues of closet qualitative research. Organ Sci. 1997;8(1):97-106.
23. Flyvbjerg B. Case study (301-316). In: Denzin NK, Lincoln YS, eds. The Sage Handbook of Qualitative Research. 4th ed. Thousand Oaks, California: Sage; 2011.
24. McCulloch P. The EU’s system for regulating medical devices. BMJ. 2012;345:e7126. doi:10.1136/bmj.e7126
25. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service organizations: Systematic review and recommendations. Milbank Q. 2004;82(4):581-629.
26. Campbell B. How to judge the value of innovation: more evidence is needed but “promise” is important early on. BMJ. 2012;344:e1457. doi:10.1136/bmj.e1457
27. Blomqvist A, Busby C, Husereau D. Capturing value from health technologies in lean times. CD Howe Institute Commentary No. 396. https://papers.ssrn.com/sol3/papers.cfm?abstract_ id=2369403. Published 2013.
28. Advisory Panel on Healthcare Innovation. Unleashing innovation: Excellent healthcare for Canada. http://healthycanadians. gc.ca/publications/health-system-systeme-sante/summary-innovation-sommaire/index-eng.php. Published 2015.
29. Stilgoe J, Owen R, Macnaghten P. Developing a framework for responsible innovation. Res Policy. 2013;42(9):1568-1580. doi:10.1016/j.respol.2013.05.008